Other voices weigh in on mammography decision
Article Abstract:
A subcommittee of the US National Cancer Institute will review the evidence for mammography in women between 40 and 49 and make its recommendation by June, 1997. In January, 1997, the agency said there was not enough evidence of benefit to endorse routine mammography in this group. Many physicians disagreed with this conclusion, and the American Cancer Society recommended annual mammograms for these women. However, many researchers are not convinced that this would produce enough benefit to be included as a covered benefit in managed care plans. It seems likely that the decision to have a mammogram will remain a personal one.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
NIH consensus panel spurs discontent
Article Abstract:
A recommendation from the National Institutes of Health (NIH) against screening women in their 40s for breast cancer has generated considerable controversy. In Jan, 1997, the NIH reviewed over 100 reports and listened to testimony from 32 researchers about the use of mammography in women 40 to 49 years old. The agency left the decision to each individual woman, a recommendation that left many in the audience angry. However, many studies showed little if any benefit and mammography is not a harmless procedure. African-American women may benefit from early screening.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Hepatitis C is focus of NIH consensus panel
Article Abstract:
A consensus panel convened by the National Institutes of Health has made several recommendations to deal with the explosion in the number of cases of end-stage liver disease that is predicted to occur as a result of hepatitis C infection. About 4 million Americans are currently infected with the hepatitis C virus, and 30,000 new cases are diagnosed each year. The infection can lead to liver cirrhosis. The panel recommends treatment with interferon alpha, but only in those groups most likely to benefit. Patients with cirrhosis should receive a liver transplant.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: How to use a clinical decision analysis: are the results of the study valid? How to use a clinical decision analysis: what are the results and will they help me care for my patients?
- Abstracts: Teratogenicity of high vitamin A intake. Urgent need to increase folic acid consumption. Vitamin A and birth defects: continuing caution is needed
- Abstracts: Infection with hepatitis GB virus C in patients on maintenance hemodialysis. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis
- Abstracts: Selling a practice. Choosing a practice: key issues to consider
- Abstracts: Ethics in subacute care. Case management in subacute care